EUROPE DIALYZER MARKET

INTRODUCTION TOEUROPE DIALYZER MARKET

For each patient's treatment, a new dialyzer is used. The filter, also known as a dialyzer, is a membrane device that filters waste chemicals from blood before returning it to patients.

Dialyzers are classified into two types: high flux and low flux. The term flux' refers to the permeability of the membrane in the dialyzer (artificial kidney) through which toxins and excess fluid move during hemodialysis.

The dialyzer's core is made up of hundreds of small mesh tubes.The blood runs through each tube, while the dialysate remains on the outside. Small pores in the tubes allow waste and surplus fluids from your blood to enter into the dialysate.

The size of the dialyzer is determined by the surface area of the semipermeable membrane, given in square meters.There are three types of dialysis machines: tube, flat, and hollow fibre.

The hollow fibre type is now the most often used dialyzer, with flat-type and tube-type dialyzers being phased out.The biocompatibility of the dialyzer material is defined by the degree of inflammatory response. Membranes are presently available in three varieties: unmodified cellulose, modified/regenerated cellulose, and synthetic.

EUROPE DIALYZER MARKET SIZE AND FORECAST

The Europe dialyzer market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

EUROPE DIALYZER MARKETNEW PRODUCT LAUNCH

Fresenius Medical Care’s new FX CorAL dialyzer combines clinical performance with hemocompatibility.The FX CorAL is a new dialyzer for hemodialysis being introduced by Fresenius Medical Care, the major supplier of goods and services for people with renal disorders worldwide.

Clinical performance and hemocompatibility were key considerations in the creation of the novel dialyzer. In addition to being offered in Switzerland, Germany, France, Italy, and the United Arab Emirates will all eventually carry the FX CorAL. Following will be other nations in the company's territory of Europe, the Middle East, and Africa.

Dialysis patients frequently experience chronic inflammation as a result of toxic material buildup and frequent exposure of their blood to foreign toxins.

These inflammatory conditions decrease patients' quality of life and help cardiovascular illnesses develop. The new Helixone hydro membrane, which generates a unique water layer that resembles a gel on the surface of the inner membrane to prevent protein adsorption while the blood is being cleansed, is the heart of the new FX CorAL. With high selective permeability for the elimination of toxins and extra water, this is intended to achieve a reduced stimulation of the immune response in the patient.

The FX CorALis the most recent dialyzer of the FX family of dialyzers made by Fresenius Medical Care, which employ polysulfone, a unique plastic with superior filtration and hemocompatibility properties.

The dialyzer's fibres have a unique shape that makes sure the dialysis solution washes uniformly around each fibre, boosting clearance.

A lateral blood input port makes therapy safer by preventing the bloodline from kinking while it is being used. This promotes a more uniform blood flow.

All FX-class dialyzers are also steam-sterilised and ecologically beneficial due to their light construction. The FX CorAL was launched at Fresenius Medical Care's NephroCare clinics after gaining the CE-mark, and it has since been utilised in more than 3 million procedures.

Hemodialysis replaces the native organ's essential functions with those of the dialyzer, which serves as an artificial kidney.

As many as 20,000 capillaries, which are incredibly tiny fibres, are gathered in a plastic tube that is around 30 centimetres long and carry blood.

Through these capillaries, metabolic toxins and extra water are removed from the blood and subsequently the body is cleansed with dialysis solution.

But the blood still contains proteins and blood cells. The typical frequency of this treatment is three times per week, with each session lasting between three and six hours.

EUROPE DIALYZER MARKETCOMPANY PROFILE

• B. Braun Melsungen AG
• China Chengdu Wesley Biotech Co.
• Baxter International Inc.
• Farmasol
• Allmed Medical Care Holdings Limited
• Medica Group

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many dialyzers are manufactured per annum in Europe? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Europe dialyzer and key vendor selection criteria
3. Where is the dialyzer manufactured? What is the average margin per unit?
4. Market share of Europe dialyzer market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Europe dialyzer in-house
6. key predictions for next 5 years in Europe dialyzer market
7. Average B-2-B dialyzer market price in all segments
8. Latest trends in dialyzer market, by every market segment
9. The market size (both volume and value) of the dialyzer market in 2023-2030 and every year in between?
10. Production breakup of dialyzer market, by suppliers and their OEM relationship